New York would become the first state to force pharmacy benefit managers to publicly reveal how much they profit from rebates issued by drug manufacturers under a measure backed by Governor Kathy Hochul, Bloomberg Law’s Zach Williams reports. Lawmakers and pharmacists say the proposal for the state budget due on April 1 would push boundaries for transparency requirements on PBMs, which manage drug benefits for employers and negotiate those prices with drugmakers. The three dominant PBMs are Cigna’s (CI) Express Scripts, CVS Caremark (CVS), and UnitedHealth’s (UNH) Optum Rx.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- American Air flight crashes in D.C., Microsoft reports Q2 beat: Morning Buzz
- Meta Platforms, CVS Health upgraded: Wall Street’s top analyst calls
- Edward Jones upgrades CVS Health to Buy on ‘turnaround story’
- CVS Health upgraded to Buy from Hold at Edward Jones
- CVS Health app to let customers unlock cabinets to pick up products